CSI Market
Sign In | Register

Mereo Biopharma Group Plc (MREO) Annual Balance Sheets

Annual · GAAP · USD millions
Access MREO quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Mereo Biopharma Group Plc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent40.99
Cash And Cash Equivalents0.40
Restricted Cash0.40
Current Tax Assets Current0.00
Cash & Short-term Investments40.00
Trade & Other Current Receivables (IFRS combined total)-
Other Receivables0.00
Notes Receivable, Current0.49
Other Current Assets1.50
Prepaid Expense And Other Assets Current0.14
Total Current Assets45.02
Equipment/Property/Plant Net1.09
Intangible Assets0.52
Tax Assets, Noncurrent226.76
Other Assets, Noncurrent0.24
Current Receivables From Taxes Other Than Income Tax-
Other Current Receivables-
Intangible Assets Other Than Goodwill-
Noncurrent Assets-
Current Prepayments-
Total Assets45.92
Liabilities
Accounts Payable, Current AC1.33
Accrued Liabilities, Current AC2.03
Financial Instruments0.00
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current0.94
Taxes Payable0.32
Current Provisions0.00
Total Current Liabilities4.30
Long-term debt0.00
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.04
Accrued Income Taxes, Noncurrent0.00
Noncurrent Provisions0.66
Current Lease Liabilities-
Warrant Liability-
Noncurrent Lease Liabilities-
Noncurrent Liabilities-
Trade And Other Current Payables-
Accruals-
Total Liabilities5.00
Stockholders' Equity
Common Stock Value3.14
Additional Paid In Capital Common Stock549.62
Retained Earnings / Accumulated Deficit-501.02
Accumulated Other Comprehensive Income-10.82
Other Equity-10.82
Common Stockholder's Equity40.92
Total Stockholder's Equity40.92
Liabilities & Stockholder's Equity45.92
4 historic quarters locked

Sign in to unlock the full Mereo Biopharma Group Plc balance sheet history.

Sign In Create Free Account

About Mereo Biopharma Group Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-115226

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License